What follows is an outsider's report on the next big phase of cardiology—the percutaneous treatment of valvular heart disease. I have little doubt that in 5 to 10 years, transcutaneous valves will be ...
The randomized ACCESS-TAVI study led by PD Dr. Tobias Rheude and DZHK-Prof. Michael Joner from the German Heart Center Munich and the German Center for Cardiovascular Research shows that a combined ...
Transcatheter aortic valve implantation has evolved as a viable therapeutic option for high-risk, elderly patients with symptomatic aortic stenosis in select cardiac centers with experience of the ...
The aortic valve is one of the heart’s four vital valves. It ensures that blood flows in one direction, from the heart to the rest of the body through the aorta. Over time, this valve can become ...